Reporte por ApprovalDate
| Country | Product | INN | Strengths | Pharma Dosage Form | Process | SubmissionDateActual | ApprovalDate | LaunchDateActual |
|---|---|---|---|---|---|---|---|---|
| MÉXICO | RAAZID | Telmisartan + HCTZ | 80 mg+12.5 mg 80 mg+25.0 mg | TABLET | ACTUAL | 16/01/2023 | - | - |
| MÉXICO | SELTAFERON | Oseltamivir | 6 mg/mL | SUSPENSION | MAJOR VARIATION | 30/10/2024 | - | - |
| MÉXICO | SENSIBIT | Loratadine | 10 mg | TABLET | RENEWAL | 09/01/2025 | - | - |
| MÉXICO | SENSIBIT | Loratadine | 10 mg | TABLET | POST APPROVAL COMMITMENT | 06/05/2025 | - | - |
| BRASIL | SENSIBIT D NF | Phenylephrine + Loratadine + Paracetamol | 2.5 mg+5 mg+500 mg | TABLET | ACTUAL | 18/02/2021 | - | - |
| MÉXICO | SENSIBIT D NF | Phenylephrine + Loratadine + Paracetamol | 2.5 mg+5 mg+500 mg | TABLET | FREE TEXT | 12/08/2024 | - | - |
| MÉXICO | SIIRRITAB | Trimebutine + Simeticone | 100 mg+37.5 mg 200 mg+75 mg | TABLET | ACTUAL | 31/07/2024 | - | - |
| MÉXICO | SUPRADOL | Ketorolac tromethamine | 30 mg/mL 60 mg/2 mL | INJECTABLE SOLUTION | MAJOR VARIATION | 30/10/2025 | - | - |
| MÉXICO | THOREVA | Atorvastatine | 10 mg 20 mg 40 mg 80 mg | TABLET | MAJOR VARIATION | 28/06/2024 | - | - |
| MÉXICO | THOREVA | Atorvastatine | 10 mg 20 mg 40 mg 80 mg | TABLET | INTERNAL CORRECTION | 13/01/2026 | - | - |
| MÉXICO | TRONIUM | Esomeprazol | 20 mg | CAPSULE | ANDA | 26/11/2024 | - | - |
| MÉXICO | TRONIUM IV | Esomeprazol | 40 mg/5 mL | SOLUTION | MODERATE VARIATION | 09/07/2025 | - | - |
| MÉXICO | TRONIUM IV | Esomeprazol | 40 mg/5 mL | SOLUTION | LEGAL PROCESS | 03/09/2025 | - | - |
| MÉXICO | TRONIUM IV | Esomeprazol | 40 mg/5 mL | SOLUTION | MAT | - | - | - |
| MÉXICO | TRONIUM IV | Esomeprazol | 40 mg/5 mL | SOLUTION | RENEWAL | - | - | - |
| MÉXICO | TRONIUM IV | Esomeprazol | 40 mg/5 mL | SOLUTION | MAJOR VARIATION | 01/10/2021 | - | - |
| MÉXICO | TRONIUM IV | Esomeprazol | 40 mg/5 mL | SOLUTION | MAJOR VARIATION | 16/12/2024 | - | - |
| MÉXICO | TRONIUM IV | Esomeprazol | 40 mg/5 mL | SOLUTION | MAJOR VARIATION | 01/10/2021 | - | - |
| MÉXICO | TUSIGEN NF | Ambroxol + Dextromethorphan | 22.5 mg+22.500 g | TABLET | MAJOR VARIATION | 11/04/2022 | - | - |
| MÉXICO | UNILOID | Hydrocortisone | 0.1 % | CREAM | ACTUAL | 15/07/2025 | - | - |
| MÉXICO | ZOLNIC | Zoledronic acid | 4 mg/5 mL | SOLUTION | MAJOR VARIATION | 19/12/2025 | - | - |
| MÉXICO | QUIMARA-1 | Imiquimod | 50 mg/g | CREAM | INTERNAL CORRECTION | 22/01/2026 | - | - |
| MÉXICO | ANALGEN NF | Naproxen + Lidocaine | 10 g+5 g | GEL | RENEWAL | 31/03/2025 | - | - |
| MÉXICO | CICLOFERON | Aciclovir | NA | SOLUTION | RENEWAL | 03/10/2024 | - | - |
| MÉXICO | CICLOFERON | Aciclovir | 5 g/100 mL | SOLUTION (SPRAY) | RENEWAL | 03/10/2024 | - | - |
| MÉXICO | FOSFONAT | Ibandronic acid | NA | TABLET | RENEWAL | 05/12/2024 | - | - |
| MÉXICO | GLIPAMET | - | NA | - | MAJOR VARIATION | 04/02/2025 | - | - |
| MÉXICO | GLIPA-MT | Sitagliptin + Metformin | NA | TABLET | TOLLING PERMIT | 25/08/2025 | - | - |
| MÉXICO | GLITACAR-1 | Pioglitazone | 15 mg 30 mg | TABLET | RENEWAL | 26/09/2022 | - | - |
| MÉXICO | L-OMBRIX-DUET | Mebendazole + Quinfamide | NA | TABLET | RENEWAL | 31/01/2025 | - | - |
| MÉXICO | MICRORGAN | Ciprofloxacin | 500 mg | TABLET | RENEWAL | 09/06/2025 | - | - |
| MÉXICO | MINOFEN | - | NA | TABLET | CANCELLATION | 24/04/2015 | - | - |
| MÉXICO | PRAZOLAN | Pantoprazol | 40 mg | SOLUTION | RENEWAL | 18/12/2024 | - | - |
| MÉXICO | QUADRILOID | - | NA | CREAM | INTERNAL CORRECTION | 10/02/2024 | - | - |
| MÉXICO | RAAZID | Telmisartan+HCTZ | NA | TABLET | INTERNAL CORRECTION | 08/07/2025 | - | - |
| MÉXICO | SOTAVENT | - | NA | TABLET | CANCELLATION | 17/04/2024 | - | - |
| MÉXICO | VIATOR-A | - | NA | TABLET | CANCELLATION | 17/04/2024 | - | - |
| MÉXICO | EVEREST | Montelukast | 10 mg | TABLET | MAJOR VARIATION | 16/12/2022 | - | - |
| MÉXICO | EVOCS-III | Levofloxacin | 500 mg 750 mg | TABLET | MAJOR VARIATION | 07/12/2022 | - | - |
| MÉXICO | FACIDEX | Famotidine | 10 mg | TABLET | RENEWAL | 22/08/2025 | - | - |
| MÉXICO | FACIDEX | Famotidine | 10 mg | TABLET | CANCELLATION | 08/07/2015 | - | - |
| MÉXICO | FLAGENASE | Metronidazole | 500 mg | ovule | MAJOR VARIATION | 22/04/2024 | - | - |
| MÉXICO | FLAGENASE | Metronidazole | 250 mg 500 mg | TABLET | MAJOR VARIATION | 01/08/2023 | - | - |
| MÉXICO | FLAGENASE | Metronidazole | 500 mg | ovule | LEGAL PROCESS | - | - | - |
| MÉXICO | FLAGENASE 400 PEDIATRICO | Metronidazole + Diiodohydroxyquinoleine | 2.5 g+2 g/100 mL | SUSPENSION | RENEWAL | 16/01/2026 | - | - |
| MÉXICO | FOCINAT | Calcium + Cholecalciferol | 315 mg/200 UI | TABLET | FIRST RENEWAL | 06/12/2022 | - | - |
| MÉXICO | GLITACAR-1 | Pioglitazone | 15 mg 30 mg | TABLET | MAJOR VARIATION | - | - | - |
| MÉXICO | INHIBITRON | Omeprazole | 40 mg/ 10mL | SOLUTION | POST APPROVAL COMMITMENT | 13/09/2024 | - | - |
| MÉXICO | INHIBITRON | Omeprazole | 1) 10 mg 2) 20 mg | CAPSULE | MAJOR VARIATION | 23/07/2024 | - | - |
| MÉXICO | INHIBITRON F | Omeprazole | 40 mg | CAPSULE | MAJOR VARIATION | 28/06/2024 | - | - |
| MÉXICO | INHIBITRON F | Omeprazole | 40 mg | CAPSULE | FREE TEXT | 09/08/2024 | - | - |
| COLOMBIA | L-OMBRIX-DUET | Mebendazole + Quinfamide | 60 mg+10 mg/mL 60 mg+20 mg/mL | SUSPENSION | ACTUAL | 06/08/2024 | - | - |
| MÉXICO | L-OMBRIX-DUET | Mebendazole + Quinfamide | 1) 60 mg+10 mg/mL 2) 60 mg+20 mg/mL | SUSPENSION | MAJOR VARIATION | 06/08/2024 | - | - |
| MÉXICO | MICRORGAN | Ciprofloxacin | 500 mg | TABLET | MAJOR VARIATION | 09/12/2025 | - | - |
| MÉXICO | MUCOVIBROL | Ambroxol | 0.300 g/100 mL 0.750 g/100 mL | SOLUTION | MAJOR VARIATION | - | - | - |
| MÉXICO | MUCOVIBROL | Ambroxol | 0.300 g/100 mL 0.750 g/100 mL | SOLUTION | PROMOTIONAL PERMIT | - | - | - |
| MÉXICO | MUCOVIBROL | Ambroxol | 0.300 g/100 mL 0.750 g/100 mL | SOLUTION | PROMOTIONAL PERMIT | - | - | - |
| MÉXICO | MUCOVIBROL | Ambroxol | 30 mg | TABLET | MAJOR VARIATION | 20/09/2024 | - | - |
| MÉXICO | MUCOVIBROL | Ambroxol | 0.300 g/100 mL 0.750 g/100 mL | SOLUTION | MAJOR VARIATION | 03/09/2025 | - | - |
| MÉXICO | MYCELVAN | Terbinafine | 0.888 g | SPRAY | ANDA | 21/03/2024 | - | - |
| MÉXICO | MYCELVAN | Terbinafine | 250 mg | TABLET | RENEWAL | 08/01/2026 | - | - |
| MÉXICO | PRAZOLAN | Pantoprazol | 40 mg | TABLET | MAJOR VARIATION | 11/09/2025 | - | - |
| MÉXICO | PRAZOLAN | Pantoprazol | 40 mg | TABLET | MAJOR VARIATION | 18/09/2025 | - | - |
| MÉXICO | PRAZOLAN | Pantoprazol | 40 mg | TABLET | MAJOR VARIATION | 29/10/2021 | - | - |
| MÉXICO | PRAZOLAN | Pantoprazol | 40 mg | TABLET | MAJOR VARIATION | 17/06/2021 | - | - |
| MÉXICO | PRAZOLAN | Pantoprazol | 40 mg | SOLUTION | MAJOR VARIATION | 28/10/2024 | - | - |
| MÉXICO | PROSIQUE | Fluoxetine | 20 mg | CAPSULE | RENEWAL | 24/10/2025 | - | - |
| MÉXICO | QUIMARA-1 | Imiquimod | 50 mg/g | CREAM | FREE TEXT | 09/08/2024 | - | - |
| MÉXICO | QUIMARA-1 | Imiquimod | 50 mg/g | CREAM | MAJOR VARIATION | 22/04/2024 | - | - |
| MÉXICO | RAAS | Telmisartan | 40 mg 80 mg | TABLET | MAJOR VARIATION | 09/11/2020 | - | - |
| MÉXICO | ALESSE-1 | Levonorgestrel | 0.75 mg | TABLET | RENEWAL | - | - | - |
| MÉXICO | ANALGEN | Naproxen | 10 g/100 g | GEL | RENEWAL | - | - | - |
| MÉXICO | ANALGEN | Naproxen | 550 mg+220 mg | TABLET | RENEWAL | 19/12/2025 | - | - |
| MÉXICO | ANALGEN FEM | Naproxen + Paracetamol + Pamabrom | 220 mg+300 mg+25 mg | TABLET | MAJOR VARIATION | 07/04/2021 | - | - |
| MÉXICO | ANALGEN NF | Naproxen + Lidocaine | 10 g+5 g | GEL | GMP | 06/11/2025 | - | - |
| MÉXICO | ASA 500 | Acetylsalicilic acid | 500 mg | CAPSULE | RENEWAL | - | - | - |
| MÉXICO | BOLT 36 | Tadalafil | 5 mg 20 mg | TABLET | RENEWAL | - | - | - |
| MÉXICO | BOLT 36 | Tadalafil | 20 mg | Gel | FIRST RENEWAL | 14/06/2025 | - | - |
| MÉXICO | BOLT 36 | Tadalafil | 20 mg | Gel | MAJOR VARIATION | 07/06/2021 | - | - |
| MÉXICO | BOLT 36 | Tadalafil | 20 mg | Gel | MAJOR VARIATION | 06/08/2024 | - | - |
| MÉXICO | BOLT 36 | Tadalafil | 5 mg 20 mg | TABLET | MAJOR VARIATION | 30/01/2023 | - | - |
| MÉXICO | CANDIDERM | Clortrimazole | 2 g | CREAM | ANDA | 17/12/2024 | - | - |
| MÉXICO | CANDIFLUX | Fluconazole | 150 mg | CAPSULE | RENEWAL | 28/11/2025 | - | - |
| MÉXICO | CEFTRIANOL | Ceftriaxone | 1 g | SOLUTION | MAJOR VARIATION | - | - | - |
| MÉXICO | CICLOFERON | Aciclovir | 200 mg 400 mg | TABLET | RENEWAL | - | - | - |
| MÉXICO | CICLOFERON | Aciclovir | 4 g/100 mL | SUSPENSION | MAJOR VARIATION | 16/10/2025 | - | - |
| MÉXICO | CILIOSTEN | Miconazole | 2 g | POWDER | RENEWAL | - | - | - |
| MÉXICO | CO-DEGREGAN | Clopidogrel bisulfate + Acetylsalicylic acid | 75 mg+100 mg | TABLET | FIRST RENEWAL | 29/09/2025 | - | - |
| MÉXICO | CO-DEGREGAN | Clopidogrel bisulfate + Acetylsalicylic acid | 75 mg+100 mg | TABLET | MAJOR VARIATION | - | - | - |
| MÉXICO | CONAZOL TALCO | Ketoconazole | 2 g/100 g 0.02 g/g | POWDER | RENEWAL | - | - | - |
| COLOMBIA | CONTINENTAL | Solifenacine | 5 mg 10 mg | TABLET | ACTUAL | 14/01/2021 | - | - |
| MÉXICO | CONTINENTAL | Solifenacine | 5 mg 10 mg | TABLET | MAJOR VARIATION | 14/01/2021 | - | - |
| MÉXICO | CONTINENTAL | Solifenacine | 5 mg 10 mg | TABLET | RENEWAL | 17/06/2021 | - | - |
| BRASIL | DAFLOXEN | Naproxen sodium | 275 mg 550 mg | TABLET | ACTUAL | 20/11/2020 | - | - |
| MÉXICO | DAKART | Dutasteride + Tamsulosin | 0.5 mg+0.4 mg | CAPSULE | MAJOR VARIATION | 28/01/2026 | - | - |
| MÉXICO | DAKART | Dutasteride + Tamsulosin | 0.5 mg+0.4 mg | CAPSULE | RENEWAL | 08/12/2025 | - | - |
| MÉXICO | DAPOSAR | Dapagliflozine | 10 mg | TABLET | ACTUAL | 28/03/2023 | - | - |
| MÉXICO | DAPOSAR | Dapagliflozine | 10 mg | TABLET | MAJOR VARIATION | 19/12/2025 | - | - |
| MÉXICO | DOSCOXEL | Etoricoxib | 60 mg 90 mg 120 mg | TABLET | MAJOR VARIATION | 30/04/2024 | - | - |
| MÉXICO | DOSCOXEL | Etoricoxib | 60 mg 90 mg 120 mg | TABLET | FREE TEXT | 10/06/2025 | - | - |
| MÉXICO | DOSCOXEL | Etoricoxib | 60 mg 90 mg 120 mg | TABLET | FREE TEXT | 09/08/2024 | - | - |
| MÉXICO | DOSCOXEL-DUO | Etoricoxib + Tramadol | 120 mg+100 mg | TABLET | MAJOR VARIATION | 20/03/2025 | - | - |
| MÉXICO | ECTAPRIM | Trimethoprim + Sulfamethoxazole | 80 mg+400 mg | TABLET | MAJOR VARIATION | 30/04/2024 | - | - |
| MÉXICO | EVEREST | Montelukast | 10 mg | TABLET | ACTUAL | 01/12/2021 | - | - |
| MÉXICO | EVEREST | Montelukast | 10 mg | TABLET | RENEWAL | - | - | - |
| MÉXICO | EVEREST | Montelukast | 10 mg | TABLET | INTERNAL CORRECTION | 17/12/2020 | - | - |